ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Unified Patient Apps: The Future Of Trial Simplicity

  A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.

• AI-Powered Breakthroughs In CNS And Pain Trials

  Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.

• eTMFs Uncovered: 5 Costly Misconceptions To Avoid

  Critically examine prevalent myths surrounding electronic Trial Master Files (eTMFs) and their integration with electronic Investigator Site Files (eISFs).

• The Ten Commandments Of Vendor Selection

  Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

• Navigating eCOA Licensing And Localization In Clinical Trials

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• Proven Process For Managing Clinical Trial Changes, Data Migrations

  Explore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.

• Patient Voice Impacts Treatment Experience

  Download this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.

• Build Versus Buy: What's The Best Tech Tool For Study Activation?

  In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.

• How eConsent Can Help Legally Authorized Representatives

  Software vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.